Tag: endocrine resistant breast cancer

#VisualAbstract: Imlunestrant with or without Abemaciclib in Advanced Breast Cancer

byAlisha Yi

December 17, 2024

1. Median progression-free survival was 9.4 months in the imlunestrant–abemaciclib group vs 5.5 months in the imlunestrant group with HR ...

Breast cancer chemoprevention may reduce mortality in lobular carcinoma-in-situ

Imlunestrant with or without Abemaciclib in Advanced Breast Cancer

byDaniel Goldshteinand1 others

December 16, 2024

1. Median progression-free survival was 9.4 months in the imlunestrant–abemaciclib group vs 5.5 months in the imlunestrant group with HR ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result